Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Michigan Institute of Urology

4 abstracts

Abstract
Intravesical local administration of pembrolizumab for treatment of bladder cancer: A novel strategy to minimize toxicity.
Org: Michigan Institute of Urology,
Abstract
Evaluation of persistence and adherence for oral and injectable androgen deprivation therapies (ADT) in United States (US) patients with prostate cancer (PC).
Org: Michigan Institute of Urology, Pfizer Inc., Sumitomo Pharma Switzerland, Analysis Group, Inc., Sumitomo Pharma America,
Abstract
Maintenance of castration with concomitant relugolix and apalutamide (Apa) in patients with high-risk localized prostate cancer (HR-LPC): 1 year update.
Org: New Jersey Urology, A Summit Health Company, MidLantic Urology LLC, Michigan Institute of Urology, Janssen Medical Affairs,
Abstract
The safety, tolerability and efficacy of LP-10 in subjects with refractory moderate to severe hemorrhagic cystitis: Phase 2a multicenter dose escalation clinical trial.
Org: Lipella Pharmaceuticals, University of California San Francisco Department of Urology, Emory University School of Medicine, Baylor College of Medicine, Vanderbilt University Medical Center,